AR071274A1 - Derivados de pregabalina , composiciones farmaceuticas que los contienen y proceso de preparacion de los mismos - Google Patents

Derivados de pregabalina , composiciones farmaceuticas que los contienen y proceso de preparacion de los mismos

Info

Publication number
AR071274A1
AR071274A1 ARP080105512A ARP080105512A AR071274A1 AR 071274 A1 AR071274 A1 AR 071274A1 AR P080105512 A ARP080105512 A AR P080105512A AR P080105512 A ARP080105512 A AR P080105512A AR 071274 A1 AR071274 A1 AR 071274A1
Authority
AR
Argentina
Prior art keywords
pregabalin
salt
exhibiting
range
acid
Prior art date
Application number
ARP080105512A
Other languages
English (en)
Inventor
Raymond Jozef Hubertus Westheim
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of AR071274A1 publication Critical patent/AR071274A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sales de adicion de ácido farmacéuticamente aceptable de pregabalina que son aislables en estado solido, particularmente en estado cristalino, suficientemente solubles en agua, y estables tanto en estado solido como en solucion, así como métodos para preparar las sales y composiciones farmacéuticas que comprenden las sales. Reivindicacion 1: Una sal de ácido sultánico de pregabalina, seleccionada de besilato de pregabalina y tosilato de pregabalina. Reivindicacion 5: La sal de la reivindicacion 2-4, la cual es besilato de pregabalina que exhibe un diagrama de XRPD sustancialmente correspondiente a la Fig. 1, que exhibe un punto de fusion (capilaridad) en el rango de 135,6-139,8°C, y/o que exhibe una endoterma de fusion en DSC en el rango de 136-138°C. Reivindicacion 6: La sal de la reivindicacion 2-4, la cual es tosilato de pregabalina que exhibe un diagrama de XRPD sustancialmente correspondiente a la Fig. 2, que exhibe un punto de fusion (capilaridad) en el rango de 132,4-134,0°C, y/o que exhibe una endoterma de fusion en DSC en el rango de 132-134°C. Reivindicacion 7: Una composicion farmacéutica, que comprende la sal de cualquiera de las reivindicaciones 1-6 y un diluyente o portador farmacéuticamente aceptable. Reivindicacion 10: Un proceso, que comprende hacer reaccionar pregabalina y un ácido sulfonico seleccionado de ácido bencensulfonico y ácido p-toluensulfonico en un solvente para formar una sal de ácido sulfonico de pregabalina.
ARP080105512A 2007-12-21 2008-12-18 Derivados de pregabalina , composiciones farmaceuticas que los contienen y proceso de preparacion de los mismos AR071274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US901707P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
AR071274A1 true AR071274A1 (es) 2010-06-09

Family

ID=40445474

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105512A AR071274A1 (es) 2007-12-21 2008-12-18 Derivados de pregabalina , composiciones farmaceuticas que los contienen y proceso de preparacion de los mismos

Country Status (5)

Country Link
US (1) US20090170945A1 (es)
EP (1) EP2242737A1 (es)
AR (1) AR071274A1 (es)
CL (1) CL2008003800A1 (es)
WO (1) WO2009080365A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009147528A1 (en) * 2008-06-02 2009-12-10 Actavis Group Ptc Ehf Improved process for preparing pregabalin
US20090312560A1 (en) * 2008-06-10 2009-12-17 Lambertus Thijs Processes for making pregabalin and intermediates therefor
EP2389933A1 (en) * 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Pregabalin Compositions
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
EP2389934A1 (en) * 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Tablet Formulations of Pregabalin
WO2012071524A1 (en) * 2010-11-24 2012-05-31 Ratiopharm Gmbh Arylsulfonate salts of fingolimod and processes for preparation thereof
EP2527319A1 (en) * 2011-05-24 2012-11-28 Laboratorios Del. Dr. Esteve, S.A. Crystalline forms of pregabalin and co-formers in the treatment of pain
US20240000727A1 (en) 2020-12-04 2024-01-04 Laboratorios Silanes S.A. De C.V. Stable coated solid pharmaceutical composition of an opioid analgesic and an anti-epileptic for pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1680082A1 (en) * 2003-10-31 2006-07-19 ALZA Corporation Compositions and dosage forms for enhanced absorption of metformin
US20070066846A1 (en) * 2005-04-11 2007-03-22 Asher Maymon Process for making (S)-Pregabalin
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.

Also Published As

Publication number Publication date
CL2008003800A1 (es) 2010-01-22
US20090170945A1 (en) 2009-07-02
EP2242737A1 (en) 2010-10-27
WO2009080365A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
AR071274A1 (es) Derivados de pregabalina , composiciones farmaceuticas que los contienen y proceso de preparacion de los mismos
ES2924193T3 (es) Procesos e intermedios para preparar un medicamento
AR085544A1 (es) Inhibidores triciclicos fusionados dobles de las cdk 4/6 y de la flt3
EA200602060A1 (ru) Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
CA2594017A1 (en) Preparation of rosuvastatin
ES2906458T3 (es) Procedimiento para fabricar derivados de pirimidina sulfamida
EA200602058A1 (ru) Производные адамантилпирролидин-2-она в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
PE20150041A1 (es) Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
EA200901379A1 (ru) Производные никотиновой кислоты как модуляторы метаботропных глутаматных рецепторов 5 подтипа
EA200971100A1 (ru) Производные фталазинона в качестве ингибиторов поли(адф-рибоза)полимеразы (parp-1)
TW201002700A (en) Processes to make apoptosis promoters
AR072557A1 (es) Proceso para preparar composiciones de medicamentos que contienen dabigatran
AR094790A1 (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
JP2016505058A5 (es)
AR047544A1 (es) Proceso para la preparacion de compuestos de triazol sustituidos
PE20061014A1 (es) Clorhidrato de lercanidipina amorfo
PE20140968A1 (es) Derivados de benzamida sustituida
BR112018001863B1 (pt) Processo para a preparação de n-[2-[[[1-(4-clorofenil)- 1h-pirazol-3-il] oxi]metil]fenil]
CL2022000374A1 (es) Métodos para preparar análogos de incretina
RU2013137753A (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[5-[2-(1-гидрокси-1-метилэтил)пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил]мочевины
RU2016106125A (ru) Соли дасатиниба в кристаллической форме
ES2352398B1 (es) N-fenetilsulfonamidas-n-sustituidas para la identificacion de actividad biologica y farmacologica.
ES2366334T3 (es) Método de preparación de clopidogrel y productos intermedios usados en el mismo.
KR101132577B1 (ko) 키마아제 억제제로서의 술폰아미드 유도체
AR052949A1 (es) Metabolitos derivados de piridina como antagonistas nk-1 para emesis

Legal Events

Date Code Title Description
FB Suspension of granting procedure